Very exciting mouse results for Leronlimab. We jus
Post# of 158771
Please keep Burger and Pestell on the clinical side of working with Leronlimab and well away from management and managerial decisions. The path set out and that we are traversing by Dr. JL is a good one that'll reward everyone: management, clinicians and investors fairly.